Pharma Journalist -

LakePharma announced the launch of the LakePharma MicroBiomanufacturing (GMP) Center in Hopkinton, MA. Located at 35 South Street, the newly-acquired 69,000-square foot building…
Read More...

Mikhail Kalinichev, Director of In Vivo Neurology at Ipsen will be joining SMi's Pain Therapeutics Conference speaker panel and cover the topic of Therapeutic Application of Botulinum…
Read More...

Microbiome Invest in London on the 23rdof May has an international panel of experts discussing key topics such as the upcoming microbiome trigger points and technologies to watch, the…
Read More...

Join a huge community of ADC specialists at the Antibodies & Antibody Drug Conjugates conference this April 9th - 10th, Copthorne Tara Hotel, London. Now in its 6th year with a…
Read More...

ProBioGen announced the signature of a non-exclusive license agreement on its proprietary human Artificial Lymph Node (HuALN) platform technology with TEVA. The unique human Artificial…
Read More...

Results from the Phase 1/2 trial (NEO1) and its ongoing extension study (NEO-EXT) show consistent safety data for Sanofi’s investigational avalglucosidase alfa (neoGAA) in patients with…
Read More...

ERT announced advanced respiratory clinical trial services that centrally collect lung function data using the Forced Oscillation Technique (FOT). This solution is available immediately…
Read More...

Bavarian Nordic A/S announced positive results from a Phase 3 pivotal study of its investigational, non-replicating smallpox vaccine, IMVAMUNE. The study achieved both of its primary…
Read More...

Circassia Pharmaceuticals announces that it has received a multi-year Innovative Technology contract for its NIOX VERO asthma management products from Vizient, Inc., the largest…
Read More...

Novartis announced that the US Food and Drug Administration (FDA) has approved a label update for Cosentyx® (secukinumab), the first interleukin-17A (IL-17A) inhibitor approved to treat…
Read More...